t+ HttflHnlrl;Date: 3L-10-20i.6

To

Mr. BhushanMokashi

ManagerBombay Stock Exchange Limited,PhirozeJeeJeebhoy Towers,Dalal Street, MUMBAT - 400 001.

Sir,

Sub: Outcome of the Board Meeting - Reg.

Ref: Our Company code no: 532041,.

The following is the outcome of the Board Meeting of the company held on 3L,t october, 2016 at 02.00P.M. at the registered office of the Company:

1" The Board has approved the un-audited financial results of the company for the quarter endedon 30th September, 201_6.

2' The Board has approved to convene Extra ordinary General Meeting of the company on 3o,hNovember, 2016 at 10.00 A.M. at the registereu office of the company for the purpose of re-appointment of Managing Director.

We are herewith enclosing un-audited financialcertified by the auditor for the quarter endedRegulations, 201-5.

This is for your information and record.

Thanking you

Yours faithfully,

J Varun VarmaDirector

results of the company & Limited Review Report30.09.2016, as per Ctause 33 (3) of SEB| (LODR)

€nces Limited

Plot No. 31, Sagar Society, Road No. 2, Banjara Hills, Hyderabad - 500 034. INDIA

Ph. : 040-23555161, 23555181, Fax : 040-40205171.Email : pharma.hindustanbio@gmail.com CIN : 126942TG1991P1C013564

HINDUSTAN BIO SCIENCES LIMITED

Plot No.31, Sagar Society, Road No.2, Banjara Hills, Hyderabad 500 034

Phone No. 235551 6 1,F ax 40205'17 1

STATEMENT OF UN AUDITED RESULTS FOR THE QUARTER ENDED 30th SEPTEMBER,2OI6(Rs. In lakhs)

st.

No. Particulars

Quarter ended Half Year ended Year Ended

31.03.2016

(Audlted)

30.09.2016

(un- audlted)

30.06.2016(un -

audited)

30.09.2015(un -

audited)

30.09.2016(un -

audited)

30.09.2015(un -

audited)

1

2

3

4l

5l

6

7

I9

10

11

12

13

14

1 5

16

lncome from Operations(a) lncome from operations(b) Other Operating lncomeTotal lncome from Operations (Net)

Expenses(a) Purchase of Traded Goods(b) Employee Benefit Expenses

( c) Selling Expenses(d) Depreciation and amortisationExpenses

e) Other Expenses

Total ExpensesProfiU(Loss) from operations beforeother Income, Finance costs andExceptional items(1 -2)Other lncomeProfiU(Loss) from ordinary activitiesbefore Finance costs and exceptionalitems(3+4)

Finance GostsProfiU(Loss) from ordinary activitiesafter finance costs but beforeexceptional items(5-6)

Exceptional itemsProtru(Loss) trom orcllnary actlvltles

lbefore tax

lTax Expenses

l(") o"t"rr"d Tax /Asset(+)Liability(-)

l1u1 current taxlNet ProfiU(Loss) from ordinarylactivities after taxExtraordinary items (Net of taxexpenses)

et ProfiU(Loss) for the period

aid-up Equity Share CapitalFace Value of the Share is Rs.10/-

)

Reserves excluding RevaluationReserves as per balance sheet ofprevious accounting yearEarnings per share (Basic and

(0.10)

lill5.07 I

oorn"'ol

7.30 I

;,,,1I

(s.46)l

0.40

(e.86)

(e.86)

:

(e.86)

tg.ael1,025.08

I

(0.13

-l5.41 |

I

0.25

6.49

12.15

(12.-1sl

(12.151

0.70

(12.85)

(12.85)

:

(12.85)

(12.85)

1,025.08

3.30

3.30

1,025.08

0.03

ur:ot l

52.481

36.4? I

5.4410.88 I

I

0.27 I

5.48

48.54

3.94

3.94

0.64

3.30

3.30

(0.221

*_uo I

33.50 I

2e.93 I

10.48 I

o.421

0.4e I

13.7e I

55.11 I

I

,r,-rt,l

(21.611

1.10

(22.711

(22.7U

(22.7U

tzi.ttt1,025.08

0.06

102.66

102.66

69.88

10.52

1.41

0.54

13.04

95.39

7.-27

7.27

1.36

5.91

5.91

. 5.91

5.91

1,025.08

'126.01

126.41

85.79

27.79

1.68

1.10

23.04

139.40

(13.3e)

(13.3e)

2.60

(15.ee)

192.30

(208.2e)

(0.4e)

(208.78)

(208.78)

1,025.08

(543.04)

12.041

\E ti*t\

otP,I

4r, ;

t,i"s,,r r

t\\

\rT

t_

HINDUSTAN BIO SCIENCES LIMITED

Plot No.31, Sagar Society Road No.2, Baniara Hills, Hyderabad 500 034

Phone No.23555161, Fax 40205171

STATEMENT OF ASSETS AND LIABILITES

1 Un Audited Financial Results were taken on record by the Board of Directors in their

meeting held on 31 .10.2016

2 Previous year figures have been regrouped wherever necessary

For

Notes:

Place: HyderabadDate : 31.10.2016

Rs. ln Lakhs

31.03.2016

1,025.08(565.76)

62.22

62.01

9.222.90

1,025.08(543.04)

36.36

57.76

9.062.55

UITY AND LIABILITIESHolders Funds

(b) Reserves and SurPlus

Non-Current Liabilities(a) Long term Borrowings

Current Liabilitiesa) Short term Borrowings

(b) Trade Payables

TOTAL EQUITY AND LIABILITIES

Non- Current Assets(a) Fixed Assets(b) Deferred Tax Asset( c) Long term Loans & Advances

current Assetsa) Stock in hand

) Trade Receivables( c) Cash and Cash Equivalents(d) Short term Loans and Advances

7.073.83

526.88

0.1 1

47.252.51

0.12

6.793.83

526.88

0.11

32.674.15

21.24

Director

VASG & ASSOCIATESChartered Accountants

# 503/A, Sth Floor, Kubera Towers,Narayanaguda, Hyderabad-500 029

Ph : 040 - 6684 9660Email vasgassociates@gmail com

info@vasg-ca.comwebsite www vasg-ca.com

Limited Review Report

Review Report toThe Board of DirectorsHindustan Bio Sciences Ltd.

We have reviewed the accompanying statement of unaudited financial results of ll4/s.Hindustan Bio Sciences Limited for the period ended 30.09.2016. This statement is theresponsibility of the Company's Management and has been approved by the Board ofDirectors. Our responsibility is to issue a report on these financial statements based onour review.

We conducted our review in accordance with the Standard on Review Engagement (SRE)2400, Engagements to Review Financial Statements issued by the institute of CharteredAccountants of India. This standard requires that we plan and perform the review toobtain moderate assurance as to whether the financial statements are free of materialmisstatement. A review is limited primarily to inquiries of company personnel andanalytical procedures applied to financial data and thus provides less assurance that anaudit. We have not performed and audit and accordingly, we do not express an auditopinion. e

Based on our review conducted as above, nothing has come to our attention that causes us

to believe that the accompanying statement of unaudited financial results prepared inaccordance with applicable accounting standards and other recognized accountingpractices and policies has not disclosed the information required to be disclosed in termsof Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements )Regulations, 2015 including the manner in which it is to be disclosed, or that it containsany material misstatement.

For VASG & ASSOCIATESChartered AccountantsFirm Reg No. 0060705

Place: HyderabadDate: 31.1A.2016

(A.Viswanatha Rao) \PartnerM.No: 29597